This weekend, the director of China’s health agency claimed that Covid-19 vaccines being produced by private and state-run groups are not very effective. This announcement comes after an Oregon congressman began pushing for more effective and compassionate vaccine property rights to be shared among the world to end the pandemic more quickly.
The Associated Press initially reported that the director of the China Centers for Disease Control, Gao Fu, claimed Chinese vaccines “don’t have a very high protection rate.” Sinovac is the privately-owned company that has been producing Covid vaccines in China. Sinopharm is a state-owned firm responsible for the same thing. International testing has revealed that the vaccines from both businesses are 50% effective in preventing moderate to severe Covid-19 symptoms.
Despite the fact that Pfizer and Moderna have both tested to be 97% and 94% effective respectively, Gao Fu casted doubt on mRNA technology in general, so both vaccines weren’t even put under consideration. This weekend, however, Gao Fu claimed that China is considering other vaccine options now, as their goal is to vaccinate 40% of it’s population by June; for reference they currently have about 5% of their 1.4 billion population vaccinated.
The US Centers for Disease Control and Prevention have claimed that 35% of US residents have received at least one of their shots by now. Earl Blumenauer is the Oregon Congressman who also discussed how access to effective vaccines “is a key to global herd immunity from COVID.”
“None of us are safe, we’re only a plane ride away form being reinfected.”
Several lawmakers share Blumenauer’s viewpoints, and have even signed a request to the Biden Administration to temporarily lift intellectual property rights to the Pfizer, Moderna, and Johnson&Johnson vaccines. “The idea is for other countries to produce effective vaccines too.”
“It’s in everyone’s interest to do this, we’ll only be safe when the whole world can be protected, but it’s hard when wealthy countries like the US bought up most of the initial supply of effective vaccines.”
“This risks further deepening of global inequities, sparking new tensions and divides, with really serious ramifications for stability and progress around the world. Letting Covid circulate in other countries will yield stronger variant strains, which may be resistant to current vaccines.”
Martha Newsome is the president of Medical Teams International, a Pacific Northwest-based organization that works to vaccinate people in poorer countries.
“It’s literally a human rights issue. I think sometimes we just think ‘I need to get my family vaccinated, I need to get my community vaccinated,’ but we will not get out of this pandemic isolation that we’re feeling until everyone is vaccinated.”
The pharmaceutical industry opposes sharing intellectual property rights, however, which Blumenaur claims is a “short-sighted, and frankly inhumane attitude to have when facing a global health crisis. If we don’t defeat this virus together, it’ll come back to bite us.”
Eric Mastrota is a Contributing Editor at The National Digest based in New York. A graduate of SUNY New Paltz, he reports on world news, culture, and lifestyle. You can reach him at firstname.lastname@example.org.